View Financial HealthK+S 배당 및 자사주 매입배당 기준 점검 0/6K+S 은(는) 현재 수익률이 0.45% 인 배당금 지급 회사입니다. 다음 지급일은 18th May, 2026 이며 배당락일은 다음과 같습니다. 13th May, 2026.핵심 정보0.4%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률1.7%배당 성장률-6.1%다음 배당 지급일18 May 26배당락일13 May 26주당 배당금n/a배당 성향-1%최근 배당 및 자사주 매입 업데이트공지 • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.Upcoming Dividend • May 09Upcoming dividend of €0.70 per shareEligible shareholders must have bought the stock before 15 May 2024. Payment date: 17 May 2024. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (4.9%).Declared Dividend • Mar 16Dividend of €0.70 announcedShareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.Upcoming Dividend • May 04Upcoming dividend of €1.00 per share at 5.8% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).Upcoming Dividend • May 06Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.1%).모든 업데이트 보기Recent updates공지 • Apr 03K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time.공지 • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027공지 • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.공지 • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026공지 • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026공지 • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026공지 • Apr 03+ 1 more updateK+S Aktiengesellschaft, Annual General Meeting, May 14, 2025K+S Aktiengesellschaft, Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time.공지 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026Reported Earnings • Nov 16Third quarter 2024 earnings: EPS and revenues exceed analyst expectationsThird quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.공지 • Nov 15K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025공지 • Oct 24+ 1 more updateK+S Group Announces CFO Changes, Effective June 1, 2025K+S Group(SDFG) appointed Jens Christian Keuthen, currently Head of Legal, Tax, Regulatory Affairs, and New Business Areas at K+S, as CFO. Company appointed Chief Financial Officer Christian Meyer as the Chairman of the Board. All new appointments are effective from June 1, 2025.Price Target Changed • Sep 09Price target decreased by 7.7% to €13.25Down from €14.35, the current price target is an average from 17 analysts. New target price is 28% above last closing price of €10.38. Stock is down 41% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year.Price Target Changed • Aug 22Price target decreased by 8.1% to €13.42Down from €14.61, the current price target is an average from 17 analysts. New target price is 26% above last closing price of €10.70. Stock is down 37% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year.Reported Earnings • Aug 15Second quarter 2024 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2024 results: €0.034 loss per share (improved from €0.24 loss in 2Q 2023). Revenue: €873.8m (up 5.8% from 2Q 2023). Net loss: €6.10m (loss narrowed 87% from 2Q 2023). Revenue exceeded analyst estimates by 9.3%. Earnings per share (EPS) also surpassed analyst estimates by 10%. Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.공지 • Aug 14K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025공지 • May 14K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025Reported Earnings • May 13First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2024 results: EPS: €0.10 (down from €1.38 in 1Q 2023). Revenue: €988.0m (down 17% from 1Q 2023). Net income: €18.6m (down 93% from 1Q 2023). Profit margin: 1.9% (down from 22% in 1Q 2023). Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) missed analyst estimates by 64%. Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year.Upcoming Dividend • May 09Upcoming dividend of €0.70 per shareEligible shareholders must have bought the stock before 15 May 2024. Payment date: 17 May 2024. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (4.9%).Declared Dividend • Mar 16Dividend of €0.70 announcedShareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.공지 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025Reported Earnings • Mar 15Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 21%. Revenue is forecast to stay flat during the next 3 years compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.공지 • Nov 24+ 1 more updateK+S Aktiengesellschaft to Report Q3, 2024 Results on Nov 14, 2024K+S Aktiengesellschaft announced that they will report Q3, 2024 results at 7:00 AM, Central European Standard Time on Nov 14, 2024New Risk • Nov 15New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 56% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 56% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (16% net profit margin).공지 • Aug 15K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024Reported Earnings • Aug 13Second quarter 2023 earnings: EPS misses analyst expectationsSecond quarter 2023 results: €0.24 loss per share (down from €1.94 profit in 2Q 2022). Revenue: €825.8m (down 45% from 2Q 2022). Net loss: €45.3m (down 112% from profit in 2Q 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is expected to decline by 4.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.0%. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.공지 • Aug 11K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024Upcoming Dividend • May 04Upcoming dividend of €1.00 per share at 5.8% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).Reported Earnings • Mar 16Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €7.88 (down from €11.35 in FY 2021). Revenue: €5.68b (up 77% from FY 2021). Net income: €1.51b (down 31% from FY 2021). Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is expected to decline by 6.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.공지 • Jan 27K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH).K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023.공지 • Jan 22K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months.공지 • Nov 13K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023Reported Earnings • Aug 13Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2022 results: EPS: €1.93 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) missed analyst estimates by 9.0%. Over the next year, revenue is forecast to grow 20%, compared to a 1.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.공지 • Aug 12K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023Price Target Changed • Jun 24Price target increased to €31.29Up from €28.68, the current price target is an average from 14 analysts. New target price is 39% above last closing price of €22.50. Stock is up 96% over the past year. The company is forecast to post earnings per share of €8.26 for next year compared to €11.35 last year.Reported Earnings • May 13First quarter 2022 earnings: Revenues miss analyst expectationsFirst quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Revenue missed analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 46%, compared to a 6.4% growth forecast for the industry in Germany.공지 • May 12K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023Upcoming Dividend • May 06Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.1%).Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to €32.38, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 81% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €35.42 per share.Price Target Changed • Apr 08Price target increased to €26.21Up from €23.56, the current price target is an average from 14 analysts. New target price is 12% below last closing price of €29.66. Stock is up 257% over the past year. The company is forecast to post earnings per share of €6.06 for next year compared to €11.35 last year.Buying Opportunity • Mar 30Now 27% undervaluedOver the last 90 days, the stock is up 70%. The fair value is estimated to be €35.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings is forecast to decline by 51% per annum over the same time period.Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year.Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year.Price Target Changed • Mar 08Price target increased to €18.92Up from €17.59, the current price target is an average from 17 analysts. New target price is 19% below last closing price of €23.30. Stock is up 135% over the past year. The company is forecast to post earnings per share of €11.83 next year compared to a net loss per share of €9.88 last year.Buying Opportunity • Feb 22Now 21% undervaluedOver the last 90 days, the stock is up 24%. The fair value is estimated to be €24.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% per annum over the last 3 years. The company has become profitable over the last year.Price Target Changed • Nov 17Price target increased to €15.32Up from €14.27, the current price target is an average from 18 analysts. New target price is approximately in line with last closing price of €14.65. Stock is up 112% over the past year. The company is forecast to post earnings per share of €8.75 next year compared to a net loss per share of €9.88 last year.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020)Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Price Target Changed • Sep 20Price target increased to €12.75Up from €11.88, the current price target is an average from 17 analysts. New target price is approximately in line with last closing price of €12.82. Stock is up 142% over the past year.Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance.Price Target Changed • Aug 04Price target increased to €11.88Up from €11.02, the current price target is an average from 15 analysts. New target price is approximately in line with last closing price of €12.32. Stock is up 95% over the past year.Price Target Changed • Jul 21Price target increased to €11.63Up from €10.85, the current price target is an average from 16 analysts. New target price is approximately in line with last closing price of €11.89. Stock is up 92% over the past year.Price Target Changed • Jun 15Price target increased to €10.86Up from €10.13, the current price target is an average from 16 analysts. New target price is 9.5% below last closing price of €12.00. Stock is up 85% over the past year.Reported Earnings • May 14First quarter 2021 earnings released: EPS €1.13 (vs €0.33 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €733.3m (up 13% from 1Q 2020). Net income: €215.7m (up €278.9m from 1Q 2020). Profit margin: 29% (up from net loss in 1Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 105 percentage points per year, which is a significant difference in performance.Price Target Changed • May 12Price target increased to €9.44Up from €8.80, the current price target is an average from 16 analysts. New target price is 8.2% below last closing price of €10.28. Stock is up 95% over the past year.Price Target Changed • Mar 20Price target decreased to €8.60Down from €9.33, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 54% over the past year.Price Target Changed • Mar 18Price target decreased to €8.49Down from €9.13, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 46% over the past year.Is New 90 Day High Low • Jan 05New 90-day high: €8.44The company is up 18% from its price of €7.15 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.57 per share.Is New 90 Day High Low • Nov 25New 90-day high: €7.25The company is up 14% from its price of €6.38 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.76 per share.Reported Earnings • Nov 13Third quarter 2020 earnings released: €10.26 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: €821.7m (down 9.2% from 3Q 2019). Net loss: €1.96b (loss widened €1.91b from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 132% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.Analyst Estimate Surprise Post Earnings • Nov 13Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 3,169%. Over the next year, revenue is forecast to grow 3.2%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.Price Target Changed • Oct 06Price target raised to €8.30Up from €7.58, the current price target is an average from 20 analysts. The new target price is 18% above the current share price of €7.04. As of last close, the stock is down 42% over the past year.Is New 90 Day High Low • Sep 22New 90-day low: €5.29The company is down 9.0% from its price of €5.80 on 24 June 2020. The German market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.99 per share.예정된 배당 지급오늘May 07 2026배당락일May 13 2026배당 지급일May 18 20265 days (배당락일 기준)다음 배당금을 받으려면 앞으로 6 days일 이내에 매수하세요지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: SDF German 시장에서 주목할만한 배당금을 지급하지 않으므로 지급이 안정적인지 확인할 필요가 없습니다.배당금 증가: SDF German 시장에서 주목할만한 배당금을 지급하지 않으므로 지급액이 증가하는지 확인할 필요가 없습니다.배당 수익률 vs 시장K+S 배당 수익률 vs 시장SDF의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (SDF)0.4%시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.6%업계 평균 (Chemicals)3.7%분석가 예측 (SDF) (최대 3년)1.7%주목할만한 배당금: SDF 의 배당금( 0.45% )은 German 시장에서 배당금 지급자의 하위 25%( 1.57% )와 비교해 주목할 만하지 않습니다.고배당: SDF 의 배당금( 0.45% )은 German 시장에서 배당금 지급자의 상위 25%( 4.55% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: SDF German 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: SDF German 시장에서 주목할만한 배당금을 지급하지 않습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 07:32종가2026/05/06 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스K+S Aktiengesellschaft는 41명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Stephen WilderAlliance Global PartnersKnut WollerBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity Research38명의 분석가 더 보기
공지 • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.
Upcoming Dividend • May 09Upcoming dividend of €0.70 per shareEligible shareholders must have bought the stock before 15 May 2024. Payment date: 17 May 2024. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (4.9%).
Declared Dividend • Mar 16Dividend of €0.70 announcedShareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.
Upcoming Dividend • May 04Upcoming dividend of €1.00 per share at 5.8% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).
Upcoming Dividend • May 06Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.1%).
공지 • Apr 03K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time.
공지 • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027
공지 • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.
공지 • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026
공지 • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026
공지 • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026
공지 • Apr 03+ 1 more updateK+S Aktiengesellschaft, Annual General Meeting, May 14, 2025K+S Aktiengesellschaft, Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time.
공지 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026
Reported Earnings • Nov 16Third quarter 2024 earnings: EPS and revenues exceed analyst expectationsThird quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
공지 • Nov 15K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025
공지 • Oct 24+ 1 more updateK+S Group Announces CFO Changes, Effective June 1, 2025K+S Group(SDFG) appointed Jens Christian Keuthen, currently Head of Legal, Tax, Regulatory Affairs, and New Business Areas at K+S, as CFO. Company appointed Chief Financial Officer Christian Meyer as the Chairman of the Board. All new appointments are effective from June 1, 2025.
Price Target Changed • Sep 09Price target decreased by 7.7% to €13.25Down from €14.35, the current price target is an average from 17 analysts. New target price is 28% above last closing price of €10.38. Stock is down 41% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year.
Price Target Changed • Aug 22Price target decreased by 8.1% to €13.42Down from €14.61, the current price target is an average from 17 analysts. New target price is 26% above last closing price of €10.70. Stock is down 37% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year.
Reported Earnings • Aug 15Second quarter 2024 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2024 results: €0.034 loss per share (improved from €0.24 loss in 2Q 2023). Revenue: €873.8m (up 5.8% from 2Q 2023). Net loss: €6.10m (loss narrowed 87% from 2Q 2023). Revenue exceeded analyst estimates by 9.3%. Earnings per share (EPS) also surpassed analyst estimates by 10%. Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
공지 • Aug 14K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025
공지 • May 14K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025
Reported Earnings • May 13First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2024 results: EPS: €0.10 (down from €1.38 in 1Q 2023). Revenue: €988.0m (down 17% from 1Q 2023). Net income: €18.6m (down 93% from 1Q 2023). Profit margin: 1.9% (down from 22% in 1Q 2023). Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) missed analyst estimates by 64%. Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year.
Upcoming Dividend • May 09Upcoming dividend of €0.70 per shareEligible shareholders must have bought the stock before 15 May 2024. Payment date: 17 May 2024. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (4.9%).
Declared Dividend • Mar 16Dividend of €0.70 announcedShareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.
공지 • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025
Reported Earnings • Mar 15Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 21%. Revenue is forecast to stay flat during the next 3 years compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
공지 • Nov 24+ 1 more updateK+S Aktiengesellschaft to Report Q3, 2024 Results on Nov 14, 2024K+S Aktiengesellschaft announced that they will report Q3, 2024 results at 7:00 AM, Central European Standard Time on Nov 14, 2024
New Risk • Nov 15New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 56% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 56% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (16% net profit margin).
공지 • Aug 15K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024
Reported Earnings • Aug 13Second quarter 2023 earnings: EPS misses analyst expectationsSecond quarter 2023 results: €0.24 loss per share (down from €1.94 profit in 2Q 2022). Revenue: €825.8m (down 45% from 2Q 2022). Net loss: €45.3m (down 112% from profit in 2Q 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is expected to decline by 4.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.0%. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.
공지 • Aug 11K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024
Upcoming Dividend • May 04Upcoming dividend of €1.00 per share at 5.8% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).
Reported Earnings • Mar 16Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €7.88 (down from €11.35 in FY 2021). Revenue: €5.68b (up 77% from FY 2021). Net income: €1.51b (down 31% from FY 2021). Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is expected to decline by 6.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.
공지 • Jan 27K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH).K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023.
공지 • Jan 22K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months.
공지 • Nov 13K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023
Reported Earnings • Aug 13Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2022 results: EPS: €1.93 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) missed analyst estimates by 9.0%. Over the next year, revenue is forecast to grow 20%, compared to a 1.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
공지 • Aug 12K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023
Price Target Changed • Jun 24Price target increased to €31.29Up from €28.68, the current price target is an average from 14 analysts. New target price is 39% above last closing price of €22.50. Stock is up 96% over the past year. The company is forecast to post earnings per share of €8.26 for next year compared to €11.35 last year.
Reported Earnings • May 13First quarter 2022 earnings: Revenues miss analyst expectationsFirst quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Revenue missed analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 46%, compared to a 6.4% growth forecast for the industry in Germany.
공지 • May 12K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023
Upcoming Dividend • May 06Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.1%).
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to €32.38, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 81% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €35.42 per share.
Price Target Changed • Apr 08Price target increased to €26.21Up from €23.56, the current price target is an average from 14 analysts. New target price is 12% below last closing price of €29.66. Stock is up 257% over the past year. The company is forecast to post earnings per share of €6.06 for next year compared to €11.35 last year.
Buying Opportunity • Mar 30Now 27% undervaluedOver the last 90 days, the stock is up 70%. The fair value is estimated to be €35.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings is forecast to decline by 51% per annum over the same time period.
Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year.
Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year.
Price Target Changed • Mar 08Price target increased to €18.92Up from €17.59, the current price target is an average from 17 analysts. New target price is 19% below last closing price of €23.30. Stock is up 135% over the past year. The company is forecast to post earnings per share of €11.83 next year compared to a net loss per share of €9.88 last year.
Buying Opportunity • Feb 22Now 21% undervaluedOver the last 90 days, the stock is up 24%. The fair value is estimated to be €24.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% per annum over the last 3 years. The company has become profitable over the last year.
Price Target Changed • Nov 17Price target increased to €15.32Up from €14.27, the current price target is an average from 18 analysts. New target price is approximately in line with last closing price of €14.65. Stock is up 112% over the past year. The company is forecast to post earnings per share of €8.75 next year compared to a net loss per share of €9.88 last year.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020)Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Price Target Changed • Sep 20Price target increased to €12.75Up from €11.88, the current price target is an average from 17 analysts. New target price is approximately in line with last closing price of €12.82. Stock is up 142% over the past year.
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance.
Price Target Changed • Aug 04Price target increased to €11.88Up from €11.02, the current price target is an average from 15 analysts. New target price is approximately in line with last closing price of €12.32. Stock is up 95% over the past year.
Price Target Changed • Jul 21Price target increased to €11.63Up from €10.85, the current price target is an average from 16 analysts. New target price is approximately in line with last closing price of €11.89. Stock is up 92% over the past year.
Price Target Changed • Jun 15Price target increased to €10.86Up from €10.13, the current price target is an average from 16 analysts. New target price is 9.5% below last closing price of €12.00. Stock is up 85% over the past year.
Reported Earnings • May 14First quarter 2021 earnings released: EPS €1.13 (vs €0.33 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €733.3m (up 13% from 1Q 2020). Net income: €215.7m (up €278.9m from 1Q 2020). Profit margin: 29% (up from net loss in 1Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 105 percentage points per year, which is a significant difference in performance.
Price Target Changed • May 12Price target increased to €9.44Up from €8.80, the current price target is an average from 16 analysts. New target price is 8.2% below last closing price of €10.28. Stock is up 95% over the past year.
Price Target Changed • Mar 20Price target decreased to €8.60Down from €9.33, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 54% over the past year.
Price Target Changed • Mar 18Price target decreased to €8.49Down from €9.13, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 46% over the past year.
Is New 90 Day High Low • Jan 05New 90-day high: €8.44The company is up 18% from its price of €7.15 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.57 per share.
Is New 90 Day High Low • Nov 25New 90-day high: €7.25The company is up 14% from its price of €6.38 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.76 per share.
Reported Earnings • Nov 13Third quarter 2020 earnings released: €10.26 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: €821.7m (down 9.2% from 3Q 2019). Net loss: €1.96b (loss widened €1.91b from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 132% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
Analyst Estimate Surprise Post Earnings • Nov 13Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 3,169%. Over the next year, revenue is forecast to grow 3.2%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.
Price Target Changed • Oct 06Price target raised to €8.30Up from €7.58, the current price target is an average from 20 analysts. The new target price is 18% above the current share price of €7.04. As of last close, the stock is down 42% over the past year.
Is New 90 Day High Low • Sep 22New 90-day low: €5.29The company is down 9.0% from its price of €5.80 on 24 June 2020. The German market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.99 per share.